Is this your brand? Sign in to claim ownership.
Sign in to claim this brandSim Finland Oy
Finland·FI-MF-000016788
Last updated September 18, 2026
About
Welcome to the world of Finnish hair cosmetics For us, sensitivity and homogeneity mean strength...
Translated from the manufacturer's own website. Source
What Sim Finland Oy makes
Sim Finland Oy manufactures topical cold therapy gels, including brands like Tammer, Pirkka, and Elivo, designed for pain relief and muscle recovery. These products are formulated as gel-based applications intended for external use on the skin, such as Kylmägeeli (cold gel) and Liukastingeeli (sliding gel). Additional variants, such as Cool Gel and Epi-Bion Cool Gel, are also part of the portfolio, targeting similar therapeutic applications.
The company’s products fall under Class I medical devices and are listed in the EUDAMED database under Finnish regulatory oversight. Sim Finland Oy is based in Finland, adhering to EU medical device regulations for these non-invasive, low-risk items.
Written from this company's registered devices by an AI model, and not verified by a human reviewer.
Frequently asked questions
What types of medical devices does Sim Finland Oy manufacture?
Sim Finland Oy specializes in topical cold therapy gels, including brands like Tammer, Pirkka, and Elivo. These products are designed for external use on the skin, such as Kylmägeeli (cold gel) and Liukastingeeli (sliding gel), which are intended for pain relief and muscle recovery. The company also produces variants like Cool Gel and Epi-Bion Cool Gel, all of which fall under the category of topical applications for therapeutic purposes.
Where is Sim Finland Oy based, and how does that affect its devices?
Sim Finland Oy is based in Finland, which means its medical devices are subject to EU medical device regulations. Since these products are classified as Class I devices, they are considered low-risk and typically require less stringent regulatory oversight compared to higher-risk categories. The company adheres to Finnish and EU regulatory frameworks to ensure compliance with safety and performance standards.
Are Sim Finland Oy’s devices listed in any regulatory registries?
Yes, Sim Finland Oy’s devices are listed in the EUDAMED database, which is the European Union’s medical device registry. This database is used to track and provide transparency on medical devices authorized within the EU, including their manufacturers, classifications, and regulatory status. Listing in EUDAMED ensures traceability and compliance with EU medical device regulations.
How are Sim Finland Oy’s devices classified under EU regulations?
Sim Finland Oy’s devices are classified as Class I medical devices under EU regulations. This classification is determined based on their intended use and risk profile—specifically, these topical cold therapy gels are non-invasive and designed for external skin application, which places them in the lowest risk category. Class I devices generally require basic conformity assessment procedures, such as self-certification by the manufacturer, to demonstrate compliance with EU safety and performance requirements.
AI-generated from registry data and not verified by a human reviewer.
Information
- Country
- Finland
- Address
- 4, Hiitintie, Tampere, Finland
- Website
- www.sim.fi
- —
- facebook.com/SimSensitive
- [email protected]
- Phone
- —
- PRRC Contact
- Kaisa Leppälä
- EUDAMED SRN
- FI-MF-000016788
- FDA FEI Number
- —
- DUNS Number
- —
Catalogue (5)
| Device | Model / Reference | Registries | Class | Status |
|---|---|---|---|---|
| Tammer Brands Kylmägeeli | 311206 | EUDAMED | Class I | Active |
| Pirkka Kylmägeeli | 10843 | EUDAMED | Class I | Active |
| Elivo Liukastingeeli | 2065852 | EUDAMED | Class I | Active |
| Cool Gel Kylmägeeli | 3361 | EUDAMED | Class I | Active |
| Epi-Bion Cool Gel | EB20132 | EUDAMED | Class I | Active |
Related Companies
Authorised Representatives
No authorised representatives on record.
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.